Terms: = Pancreatic cancer AND FOXA1, TCF3A, 3169, ENSG00000129514, P55317, HNF3A, MGC33105 AND Prognosis
2 results:
1. Smarcd3 is an epigenetic modulator of the metabolic landscape in pancreatic ductal adenocarcinoma.
Ferguson LP; Gatchalian J; McDermott ML; Nakamura M; Chambers K; Rajbhandari N; Lytle NK; Rosenthal SB; Hamilton M; Albini S; Wartenberg M; Zlobec I; Galván JA; Karamitopoulou E; Vavinskaya V; Wascher A; Lowy AM; Schürch CM; Puri PL; Bruneau BG; Hargreaves DC; Reya T
Nat Commun; 2023 Jan; 14(1):292. PubMed ID: 36653361
[TBL] [Abstract] [Full Text] [Related]
2. A novel FBW7/NFAT1 axis regulates cancer immunity in sunitinib-resistant renal cancer by inducing PD-L1 expression.
Liu W; Ren D; Xiong W; Jin X; Zhu L
J Exp Clin Cancer Res; 2022 Jan; 41(1):38. PubMed ID: 35081978
[TBL] [Abstract] [Full Text] [Related]